Monica Michail an Oncology/Hematology Research Pharmacist with expertise in Phase I–III clinical trials, cellular therapies, and investigational oncology programs. Her work focuses on translating complex protocols into clinical practice, supporting novel therapeutic modalities including CAR-T, NK cell, stem cell transplant, gene therapies and targeted oncology therapies. Monica collaborates with investigators, sponsors, and multidisciplinary teams to implement innovative clinical trials, optimize patient safety strategies, and advance the development of emerging cancer therapies. Her experience spans both solid tumors and hematologic malignancies, with a particular interest in cell and gene therapies, precision oncology, and the operational challenges associated with bringing novel treatments from development into clinical practice. As a speaker at Advanced Therapies USA 2026, Monica brings a site-based perspective on clinical trial execution, protocol implementation, and the practical considerations required for successful delivery of advanced therapies in real-world oncology settings.